MAIN MENU
QUICK LINKS
CONNECT WITH US

Button

Clinical Trial Details

Title
A Cluster Randomized, Multi-center, Parallel-group, Rater-blind Study Comparing Treatment with Aripiprazole Once Monthly and Treatment as Usual on Effectiveness in First Episode and Early Phase Illness in Schizophrenia
Study Purpose
The purpose of the PRELAPSE study is to compare standard treatment with treatment with a version of the medication aripiprazole that is taken only once each month.
Study Plan
Study participants at some centers will receive once monthly aripiprazole and participants at other centers will receive the care the center usually provides. At the end of the study, we will compare how well participants at the two types of sites did in order to determine if participants receiving the medication once a month had less days in the hospital and had better health outcomes. All participants at this center will receive the once monthly aripiprazole.
Investigators

Principal Investigator
Steven P. Cuffe, M.D., FACPsych
Psychiatry

Co-Principal Investigator
Phyliss N. Taylor, M.D.
Psychiatry